Fig. 7.

Inflammation and hypometabolism in patients with Parkinson's disease and dementia. The left column shows inflammation as revealed by a significant binding of [¹¹C]PK11195. The right column shows regions with significant reduction of CMR_glc as identified by using [¹⁸F]FDG-PET (note that brighter color indicates reduced metabolism). Blue arrows indicate regions with severe hypometabolism and no [¹¹C]PK11195 binding, green arrows indicate those regions with a high [¹¹C]PK11195 binding which do not show reductions in metabolism. [This figure is composed from images taken from Fig. 1, Fig. 3 in Edison et al. (2013). Reprinted by permission from Macmillan Publishers Ltd: Neuropsychopharmacology (Edison et al. (2013)), copyright 2013.]